Paul Angulo

35.6k total citations · 12 hit papers
155 papers, 26.6k citations indexed

About

Paul Angulo is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Paul Angulo has authored 155 papers receiving a total of 26.6k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Epidemiology, 106 papers in Hepatology and 34 papers in Surgery. Recurrent topics in Paul Angulo's work include Liver Disease Diagnosis and Treatment (121 papers), Liver Diseases and Immunity (77 papers) and Liver Disease and Transplantation (47 papers). Paul Angulo is often cited by papers focused on Liver Disease Diagnosis and Treatment (121 papers), Liver Diseases and Immunity (77 papers) and Liver Disease and Transplantation (47 papers). Paul Angulo collaborates with scholars based in United States, Australia and Italy. Paul Angulo's co-authors include Keith D. Lindor, Leon A. Adams, Schuyler O. Sanderson, Ariel E. Feldstein, James Lymp, Phunchai Charatcharoenwitthaya, Einar S. Björnsson, Felicity Enders, Roberta A. Jorgensen and Jill C. Keach and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Paul Angulo

152 papers receiving 25.9k citations

Hit Papers

Nonalcoholic Fatty Liver Disease 2002 2026 2010 2018 2002 2007 2005 2015 2003 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nonalcoholic Fatty Liver Disease
    2002 4.3k citations Paul Angulo profile →
  2. The NAFLD fibrosis score
    2007 2.3k citations Paul Angulo, Felicity Enders et al. Hepatology profile →
  3. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
    2005 2.2k citations Leon A. Adams, Keith D. Lindor et al. Gastroenterology profile →
  4. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
    2015 2.1k citations Paul Angulo, David E. Kleiner et al. Gastroenterology profile →
  5. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
    2003 860 citations Ariel E. Feldstein, Ali Canbay et al. Gastroenterology profile →
  6. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
    2004 722 citations Leon A. Adams, Keith D. Lindor et al. Journal of Hepatology profile →
  7. Non‐alcoholic fatty liver disease
    2002 672 citations Paul Angulo, Keith D. Lindor Journal of Gastroenterology and Hepatology profile →
  8. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
    2009 550 citations Ariel E. Feldstein, Phunchai Charatcharoenwitthaya et al. profile →
  9. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
    2004 545 citations Keith D. Lindor, Roberta A. Jorgensen et al. Hepatology profile →
  10. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
    2014 528 citations Paul Angulo et al. profile →
  11. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
    2015 386 citations Paul Angulo et al. profile →
  12. Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
    2013 377 citations Paul Angulo, Einar S. Björnsson et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Angulo United States 72 22.1k 11.8k 9.3k 5.9k 3.4k 155 26.6k
Michael Charlton United States 69 19.5k 0.9× 12.9k 1.1× 6.2k 0.7× 5.4k 0.9× 2.3k 0.7× 250 25.3k
Kris V. Kowdley United States 86 20.1k 0.9× 14.5k 1.2× 5.1k 0.6× 5.6k 1.0× 2.1k 0.6× 451 29.4k
Arthur J. McCullough United States 73 28.2k 1.3× 12.0k 1.0× 12.0k 1.3× 6.0k 1.0× 5.3k 1.5× 293 35.4k
Brent A. Neuschwander‐Tetri United States 67 25.1k 1.1× 10.2k 0.9× 11.3k 1.2× 5.0k 0.9× 3.4k 1.0× 188 30.8k
Christopher P. Day United Kingdom 86 23.0k 1.0× 10.2k 0.9× 9.9k 1.1× 3.7k 0.6× 5.0k 1.5× 186 31.1k
Leon A. Adams Australia 62 18.9k 0.9× 9.1k 0.8× 7.9k 0.8× 3.1k 0.5× 3.0k 0.9× 202 22.9k
Elisabetta Bugianesi Italy 77 27.9k 1.3× 10.6k 0.9× 12.9k 1.4× 4.4k 0.7× 4.2k 1.2× 298 33.3k
Geoffrey C. Farrell Australia 76 19.9k 0.9× 10.0k 0.8× 6.9k 0.7× 3.7k 0.6× 3.0k 0.9× 213 26.1k
Quentin M. Anstee United Kingdom 73 19.7k 0.9× 8.9k 0.8× 7.9k 0.9× 3.1k 0.5× 2.7k 0.8× 254 23.9k
Mark L. Van Natta United States 41 14.7k 0.7× 6.3k 0.5× 5.5k 0.6× 3.0k 0.5× 1.8k 0.5× 111 19.2k

Countries citing papers authored by Paul Angulo

Since Specialization
Citations

This map shows the geographic impact of Paul Angulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Angulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Angulo more than expected).

Fields of papers citing papers by Paul Angulo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Angulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Angulo. The network helps show where Paul Angulo may publish in the future.

Co-authorship network of co-authors of Paul Angulo

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Angulo. A scholar is included among the top collaborators of Paul Angulo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Angulo. Paul Angulo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angulo, Paul. (2015). Nonalcoholic fatty liver disease. Nature Reviews Disease Primers. 1(1). 15081–15081. 15 indexed citations
2.
Angulo, Paul, David E. Kleiner, Sanne Dam‐Larsen, et al.. (2015). Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 149(2). 389–397.e10. 2123 indexed citations breakdown →
3.
Treeprasertsuk, Sombat, Abel Romero‐Corral, Virend K. Somers, et al.. (2014). Association of adiposity, measures of metabolic dysregulation, and elevated alanine aminotransferase in subjects with normal body mass index. Asian Biomedicine. 8(5). 585–596.
4.
Carter‐Kent, Christine, Lisa Yerian, Elizabeth M. Brunt, et al.. (2009). Nonalcoholic Steatohepatitis in Children. Hepatology. 50(4). 1113–1120. 156 indexed citations
5.
Nobili, Valério, Melania Manco, Rita De Vito, et al.. (2008). S1906 Lifestyle Intervention and Antioxidants in Children with Nonalcoholic Fatty Liver Disease: A Randomized, Controlled Trial. Gastroenterology. 134(4). A–781. 3 indexed citations
6.
Charatcharoenwitthaya, Phunchai, Paul Angulo, Felicity Enders, & Keith D. Lindor. (2007). Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis. Hepatology. 47(1). 133–142. 26 indexed citations
7.
Charatcharoenwitthaya, Phunchai, Cynthia Levy, Paul Angulo, et al.. (2007). Open‐label pilot study of folic acid in patients with nonalcoholic steatohepatitis. Liver International. 27(2). 220–226. 19 indexed citations
8.
Silveira, Marina G., Jayant A. Talwalkar, Paul Angulo, & Keith D. Lindor. (2007). Overlap of Autoimmune Hepatitis and Primary Biliary Cirrhosis: Long-Term Outcomes. The American Journal of Gastroenterology. 102(6). 1244–1250. 109 indexed citations
9.
Nobili, Valério, Matilde Marcellini, Rita De Vito, et al.. (2006). NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice. Hepatology. 44(2). 458–465. 270 indexed citations
10.
Talwalkar, Jayant A., Paul Angulo, Daniel C. Johnson, Bret T. Petersen, & Keith D. Lindor. (2004). Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis. Hepatology. 40(1). 39–45. 72 indexed citations
11.
Adams, Leon A., Ariel E. Feldstein, Keith D. Lindor, & Paul Angulo. (2004). Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology. 39(4). 909–914. 195 indexed citations
12.
Feldstein, Ariel E., Ali Canbay, Paul Angulo, et al.. (2003). Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology. 125(2). 437–443. 860 indexed citations breakdown →
13.
Angulo, Paul, et al.. (2002). Primary sclerosing cholangitis.. PubMed. 48(2). 99–113. 8 indexed citations
14.
Neuman, Manuela G., Paul Angulo, Izabella M. Malkiewicz, et al.. (2002). Tumor necrosis factor‐α and transforming growth factor‐β reflect severity of liver damage in primary biliary cirrhosis. Journal of Gastroenterology and Hepatology. 17(2). 196–202. 116 indexed citations
15.
Angulo, Paul & Keith D. Lindor. (2002). Treatment of non-alcoholic steatohepatitis. Best Practice & Research Clinical Gastroenterology. 16(5). 797–810. 55 indexed citations
16.
Angulo, Paul & Keith D. Lindor. (2001). Insulin resistance and mitochondrial abnormalities in NASH: A cool look into a burning issue. Gastroenterology. 120(5). 1281–1285. 57 indexed citations
17.
Angulo, Paul, James B. Peter, M. Eric Gershwin, et al.. (2000). Serum autoantibodies in patients with primary sclerosing cholangitis. Journal of Hepatology. 32(2). 182–187. 108 indexed citations
18.
Kaya, Muhsin, Bret T. Petersen, Paul Angulo, & Keith D. Lindor. (2000). Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis. Gastroenterology. 118(4). A902–A902. 12 indexed citations
19.
Angulo, Paul, Kenneth P. Batts, Terry M. Therneau, et al.. (1999). Long–Term Ursodeoxycholic Acid Delays Histological Progression in Primary Biliary Cirrhosis. Hepatology. 29(3). 644–647. 154 indexed citations
20.
Angulo, Paul, Roberta A. Jorgensen, Kathleen S. Egan, et al.. (1998). Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. Journal of Hepatology. 29(5). 729–735. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Charlton Breakdown of academic impact, for papers by Kris V. Kowdley Breakdown of academic impact, for papers by Arthur J. McCullough Breakdown of academic impact, for papers by Brent A. Neuschwander‐Tetri Breakdown of academic impact, for papers by Christopher P. Day Breakdown of academic impact, for papers by Leon A. Adams Breakdown of academic impact, for papers by Elisabetta Bugianesi Breakdown of academic impact, for papers by Geoffrey C. Farrell Breakdown of academic impact, for papers by Quentin M. Anstee Breakdown of academic impact, for papers by Mark L. Van Natta
Rankless by CCL
2026